Efficacy of Peritonsillar Dexmedetomidine Infiltration for Postadenotonsillectomy Pain

NCT02013570 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2013-12-17

No results posted yet for this study

Summary

The purpose of the present study is the clinical assessment of the efficacy of preincisional peritonsillar infiltration of dexmedetomidine on postoperative pain relief in children undergoing adenotonsillectomy.

Conditions

  • Pain Postoperative, Intraoperative Hemorrhage

Interventions

DRUG

Dexmedetomidine

2µg/kg dexmedetomidine in 2 ml normal saline (1 ml per tonsil),

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2013-12-31
Completion
2013-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02013570 on ClinicalTrials.gov